THE ECONOMIC COST OF CHRONIC LOW BACK PAIN
| dc.contributor.author | Yumuşakhuylu, Yasemin | |
| dc.contributor.author | Baklacioglu, Hatice Sule | |
| dc.contributor.author | Aras, Huriye | |
| dc.contributor.author | Atlig, Raife Sirin | |
| dc.contributor.author | Haliloglu, Sema | |
| dc.contributor.author | Turgut, Selin Turan | |
| dc.contributor.author | İçağasıoğlu, Afitap | |
| dc.date.accessioned | 2025-05-10T19:28:36Z | |
| dc.date.issued | 2012 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description | IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium -- MAR 21-24, 2012 -- Bordeaux, FRANCE | |
| dc.description.abstract | [No abstract available] | |
| dc.description.sponsorship | Int Osteoporosis Fdn (IOF),European Soc Clin & Econom Aspects Osteoporosis & Osteoarthritis (ESCEO),Rottapharm,Madaus,Wisepress,Servier Int,Amgen,GlaxoSmithKline (GSK),MSD,B-Cube AG,Beammed,Danone,Dfine Europe,D3A,Eli Lilly,Expanscience,GE Healthcare,Hologic,IDS,Medi,Medtron,Mindways,Nycomed,Optasia Med,Pfizer | |
| dc.identifier.endpage | S244 | |
| dc.identifier.issn | 0937-941X | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | S244 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/7392 | |
| dc.identifier.volume | 23 | |
| dc.identifier.wos | WOS:000309259600371 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Springer London Ltd | |
| dc.relation.ispartof | Osteoporosis International | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.title | THE ECONOMIC COST OF CHRONIC LOW BACK PAIN | |
| dc.type | Conference Object |










